Document is current
Any future updates will be listed below
-
Authors
Ji, Changyi
Sigurdsson, Einar M. https://orcid.org/0000-0003-1451-0952
-
Funding
Funding for this research was provided by:
National Institutes of Health (AG032611, NS077239, AG069475, NS120488)
- License Information
-
More Information
Article History
Accepted: 22 May 2021
First Online: 8 June 2021
Declarations
:
: This article was supported by National Institutes of Health grants R01 AG032611, R01 NS077239, R21 AG069475, and RF1 NS120488.
: Einar M. Sigurdsson is an inventor on several patents that are assigned to New York University. Some of the patents on tau immunotherapies and related diagnostics are licensed to H. Lundbeck A/S. In the last 36 months, Einar M. Sigurdsson received a speaking honorarium, consulting fee, and travel support to give a seminar at Biogen, Cambridge, MA, USA. Changyi Ji has no conflicts of interest that are directly relevant to the content of this article.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Both authors wrote and edited the manuscript, and read and approved the final version.
